Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:1569-1575

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, Y. F.
Right arrow Articles by Epstein, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y. F.
Right arrow Articles by Epstein, S. E.
Related Collections
Right arrow Animal models of human disease
Right arrow Growth factors/cytokines
Right arrow Ischemic biology - basic studies
Right arrow Other Vascular biology

(Circulation. 1999;100:1569-1575.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Cytomegalovirus Infection of Rats Increases the Neointimal Response to Vascular Injury Without Consistent Evidence of Direct Infection of the Vascular Wall

Yi Fu Zhou, MD; Matie Shou, MD; Esther Guetta, PhD; Raul Guzman, MD; Ellis F. Unger, MD; Zu Xi Yu, MD; Jun Zhang, MD; Toren Finkel, MD, PhD; Stephen E. Epstein, MD

From the Cardiovascular Research Foundation, Washington Hospital Center, Washington, DC, and the Cardiology Branch, NHLBI, and Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Md.

Correspondence to Yi Fu Zhou, MD, Cardiovascular Research Foundation, Suite 4B-1, 110 Irving St, Washington Hospital Center, Washington, DC 20010. E-mail yfz1{at}mhg.edu

Background—Previous studies suggest that infection may play a role in restenosis and atherogenesis; cytomegalovirus (CMV) is one of the implicated pathogens. To determine a potential causal role of CMV in these disease processes, we assessed whether CMV infection increases the neointimal response to injury of the rat carotid artery.

Methods and Results—Carotid injury was performed on 60 rats; immediately thereafter, 30 rats were infected with rat CMV, and the other 30 were mock-infected. Six weeks later, rats were euthanized, and the salivary glands, spleen, and carotid arteries were harvested. CMV infection was associated with significant exacerbation of the neointimal response to injury (neointimal to medial ratio 0.81±0.59 versus 0.31±0.38 in CMV-infected versus control rats; P<0.0001). This occurred despite absence of infectious virus from vascular tissues and detection of CMV DNA by polymerase chain reaction in the injured artery only at day 3 after infection. Persistent distant infection, associated with systemic cytokine response, was evidenced by isolation of infectious virus from homogenates of both salivary glands and spleen and by higher serum levels of interleukin (IL)-2 and IL-4 (but not interferon-{gamma} and tumor necrosis factor-{alpha}) in infected versus noninfected rats.

Conclusions—CMV infection of immunocompetent adult rats increases the neointimal response to vascular injury, suggesting that CMV may play a causal role in atherosclerosis/restenosis. Importantly, this CMV-induced response occurs even without the presence of virus in the vascular wall, suggesting that inflammatory and immune responses to infection of nonvascular tissues may contribute to the vascular response to injury.


Key Words: viruses • balloon • restenosis • atherosclerosis • cytokines




This article has been cited by other articles:


Home page
CirculationHome page
S. E. Epstein, J. Zhu, A. H. Najafi, and M. S. Burnett
Insights Into the Role of Infection in Atherogenesis and in Plaque Rupture
Circulation, June 23, 2009; 119(24): 3133 - 3141.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. B. Gombos, V. Wolan, K. McDonald, and D. G. Hemmings
Impaired vascular function in mice with an active cytomegalovirus infection
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H937 - H945.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. A. Bolovan-Fritts and S. A. Spector
Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction
Blood, January 1, 2008; 111(1): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. G. H. Betjes, N. H. R. Litjens, and R. Zietse
Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3298 - 3303.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. A. Bolovan-Fritts, R. N. Trout, and S. A. Spector
High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage
Blood, September 15, 2007; 110(6): 1857 - 1863.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
F.C. Gibson III, H. Yumoto, Y. Takahashi, H.-H. Chou, and C.A. Genco
Innate Immune Signaling and Porphyromonas gingivalis-accelerated Atherosclerosis
Journal of Dental Research, February 1, 2006; 85(2): 106 - 121.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. J. Lindsberg and A. J. Grau
Inflammation and Infections as Risk Factors for Ischemic Stroke
Stroke, October 1, 2003; 34(10): 2518 - 2532.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. B. Muhlestein and J. L. Anderson
Infectious Serology and Atherosclerosis: How Burdensome Is the Risk?
Circulation, January 21, 2003; 107(2): 220 - 222.
[Full Text] [PDF]


Home page
CirculationHome page
H. D. Danenberg, F. G. P. Welt, M. Walker III, P. Seifert, G. S. Toegel, and E. R. Edelman
Systemic Inflammation Induced by Lipopolysaccharide Increases Neointimal Formation After Balloon and Stent Injury in Rabbits
Circulation, June 18, 2002; 105(24): 2917 - 2922.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. E. Epstein
The Multiple Mechanisms by Which Infection May Contribute to Atherosclerosis Development and Course
Circ. Res., January 11, 2002; 90(1): 2 - 4.
[Full Text] [PDF]


Home page
StrokeHome page
D. Virok, Z. Kis, L. Karai, L. Intzedy, K. Burian, A. Szabo, B. Ivanyi, E. Gonczol, and M. S. Elkind
Chlamydia pneumoniae in Atherosclerotic Middle Cerebral Artery Editorial Comment
Stroke, September 1, 2001; 32(9): 1973 - 1976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. M. TIKKANEN, E. A. KALLIO, C. A. BRUGGEMAN, P. K. KOSKINEN, and K. B. LEMSTROM
Prevention of Cytomegalovirus Infection-enhanced Experimental Obliterative Bronchiolitis by Antiviral Prophylaxis or Immunosuppression in Rat Tracheal Allografts
Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 672 - 679.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Guetta, E. M Scarpati, and P. E DiCorleto
Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity
Cardiovasc Res, June 1, 2001; 50(3): 538 - 546.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. E. Epstein, J. Zhu, M. S. Burnett, Y. F. Zhou, G. Vercellotti, and D. Hajjar
Infection and Atherosclerosis : Potential Roles of Pathogen Burden and Molecular Mimicry
Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1417 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. F. Zhou, M. Shou, R. F Harrell, Z. X. Yu, E. F Unger, and S. E Epstein
Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury
Cardiovasc Res, March 1, 2000; 45(4): 1019 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. M. Miller
Gender, Estrogen, and NOS : Cautions About Generalizations
Circ. Res., November 26, 1999; 85(11): 979 - 981.
[Full Text] [PDF]